Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors
Open accessThe DOI matches its Crossref record; 318 of the 318 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To establish evidence-based recommendations for the molecular analysis of lung cancers that are required to guide EGFR- and ALK-directed therapies, addressing which patients and samples should be tested, and when and how testing should be performed. PARTICIPANTS: Three cochairs without conflicts of interest were selected, one from each of the 3 sponsoring professional societies: College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Writing and advisory panels were constituted from additional experts from these societies. EVIDENCE: Three unbiased literature searches of electronic databases were performed to capture published articles from January 2004 through February 2012, yielding 1533 articles whose abstracts were screened to identify 521 pertinent articles that were then reviewed in detail for their relevance to the recommendations. EVIDENCE was formally graded for each recommendation. CONSENSUS PROCESS: Initial recommendations were formulated by the cochairs and panel members at a public meeting. Each guideline section was assigned to at least 2 panelists. Drafts were circulated to the writing panel (version 1), advisory panel (version 2), and the public (version 3) before submission (version 4). CONCLUSIONS: The 37 guideline items address 14 subjects, including 15 recommendations (evidence grade A/B). The major recommendations are to use testing for EGFR mutations and ALK fusions to guide patient selection for therapy with an epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) inhibitor, respectively, in all patients with advanced-stage adenocarcinoma, regardless of sex, race, smoking history, or other clinical risk factors, and to prioritize EGFR and ALK testing over other molecular predictive tests. As scientific discoveries and clinical practice outpace the completion of randomized clinical trials, evidence-based guidelines developed by expert practitioners are vital for communicating emerging clinical standards. Already, new treatments targeting genetic alterations in other, less common driver oncogenes are being evaluated in lung cancer, and testing for these may be addressed in future versions of these guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–318 of 318
Boldrini, L., Gisfredi, S., Ursino, S., Camacci, T., Baldini, E., Melfi, F. M. A., & Fontanini, G. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31815ba1fa · Cited by 104
Soh, J., Toyooka, S., Aoe, K., Asano, H., Ichihara, S., Katayama, H., Hiraki, A., Kiura, K., Aoe, M., Sano, Y., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22190 · Cited by 103
Mucoepidermoid carcinoma of lung: Potential target of EGFR-directed treatment
Han, S., Kim, H., Jeon, Y. K., Oh, D., Lee, S., Kim, D., Im, S., Chung, D. H., Heo, D. S., Bang, Y., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2007.11.014 · Cited by 103
Lee, S. Y., Kim, M. J., Jin, G., Yoo, S. S., Park, J. Y., Choi, J. E., Jeon, H. S., Cho, S., Lee, E. B., Cha, S. I., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f0beca · Cited by 102
Preclinical validation of fluorescence in situ hybridization assays for clinical practice
Wiktor, A. E., Dyke, D. L. V., Stupca, P. J., Ketterling, R. P., Thorland, E. C., Shearer, B. M., Fink, S. R., Stockero, K. J., Majorowicz, J. R., & Dewald, G. W. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000195645.00446.61 · Cited by 102
PCR artifacts in LOH and MSI analysis of microdissected tumor cells
Sieben, N. L. G., ter Haar, N. T., Cornelisse, C. J., Fleuren, G. J., & Cleton-Jansensen, A.-M. (2000) · Human Pathology · doi:10.1016/s0046-8177(00)80013-1 · Cited by 101
Girard, N., Deshpande, C. G., Azzoli, C. G., Rusch, V. W., Travis, W. D., Ladanyi, M., & Pao, W. J. (2009) · CHEST Journal · doi:10.1378/chest.09-0325 · Cited by 99
Self-citationTang, X., Varella‐Garcia, M., Xavier, A. C., Massarelli, E., Ozburn, N. C., Moran, C. A., & Wistuba, I. I. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0032 · Cited by 99
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer
Feng, Y., Thiagarajan, P. S., & Ma, P. C. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182417e44 · Cited by 98
Mutational analysis of EGFR and K-RAS genes in lung adenocarcinomas
Soung, Y. H., Lee, J. W., Kim, S. Y., Seo, S. H., Park, W. S., Nam, S. W., Song, S. Y., Han, J. H., Park, C. K., Lee, J. Y., et al. (2005) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-005-1254-y · Cited by 98
Leidner, R. S., Fu, P., Clifford, B. T., Hamdan, A., Jin, C., Eisenberg, R., Boggon, T. J., Skokan, M. C., Franklin, W. A., Cappuzzo, F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1431 · Cited by 98
Mascarello, J. T., Hirsch, B. A., Kearney, H. M., Ketterling, R. P., Olson, S. B., Quigley, D. I., Rao, K. W., Tepperberg, J. H., Tsuchiya, K. D., & Wiktor, A. E. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182227295 · Cited by 98
Chromosome abnormalities in human non-small cell lung cancer.
Testa, J. R., & Siegfried, J. M. (1992) · PubMed · Cited by 96
Sugio, K., Uramoto, H., Onitsuka, T., Mizukami, M., Ichiki, Y., Sugaya, M., Yasuda, M., Takenoyama, M., Oyama, T., Hanagiri, T., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.09.010 · Cited by 95
Blons, H., Côté, J.-F., Le Corre, D., Riquet, M., Fabre-Guilevin, E., Laurent-Puig, P., & Danel, C. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213285.65907.31 · Cited by 93
Endoh, H., Yatabe, Y., Kosaka, T., Kuwano, H., & Mitsudomi, T. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)30374-9 · Cited by 90
Hoshi, K., Takakura, H., Mitani, Y., Tatsumi, K., Momiyama, N., Ichikawa, Y., Togo, S., Miyagi, T., Kawai, Y., Kogo, Y., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0509 · Cited by 90
Engelman, J. A., & Cantley, L. C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0795 · Cited by 90
Betz, B. L., Roh, M. H., Weigelin, H. C., Placido, J. B., Schmidt, L. A., Farmen, S., Arenberg, D. A., Kalemkerian, G. P., & Knoepp, S. M. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcp84tutqosuong · Cited by 88
Fukui, T., Ohe, Y., Tsuta, K., Furuta, K., Sakamoto, H., Takano, T., Nokihara, H., Yamamoto, N., Sekine, I., Kunitoh, H., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5207 · Cited by 88
Significance of epidermal growth factor receptor gene mutations in squamous cell lung carcinoma
Shimizu (2011) · Oncology Reports · doi:10.3892/or.2011.1182 · Cited by 88
Macarenco, R., Uphoff, T. S., Gilmer, H. C. F., Jenkins, R. B., Thibodeau, S. N., Lewis, J. E., Molina, J. R., Yang, P., & Aubry, M.-C. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.113 · Cited by 87
Self-citationRelationship between EGFR expression, copy number and mutation in lung adenocarcinomas
Liang, Z., Zhang, J., Zeng, X., Gao, J., Wu, S., & Liu, T. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-376 · Cited by 87
Hsieh, M., Fang, Y., Chang, W.-C., Kuo, H.-P., Lin, S.-Y., Liu, H.-P., Liu, C.-L., Chen, H.-C., Ku, Y.-C., Chen, Y.-T., et al. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.06.005 · Cited by 86
Penzel, R., Sers, C., Chen, Y., Lehmann-Mühlenhoff, U., Merkelbach‐Bruse, S., Jung, A., Kirchner, T., Büttner, R., Kreipe, H. H., Petersen, I., et al. (2010) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-010-1000-y · Cited by 85
Dufort, S., Richard, M.-J., Lantuejoul, S., & de Fraipont, F. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-57 · Cited by 84
Sun, L., Zhang, Q., Luan, H., Zhan, Z., Wang, C., & Sun, B. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-30 · Cited by 83
EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients
Bae, N. C., Chae, M. H., Lee, M. H., Kim, K. M., Lee, E. B., Kim, C. H., Park, T.-I., Han, S. B., Jheon, S., Jung, T. H., et al. (2007) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2006.10.007 · Cited by 82
Wu, C., Hsu, H., Liu, H., Chang, J. W., Chen, Y., Hsieh, W.-Y., Hsieh, J., Hsieh, M., Chen, Y., & Huang, S. (2008) · Cancer · doi:10.1002/cncr.23925 · Cited by 82
Cote, M. L., Haddad, R., Edwards, D. J., Atikukke, G., Gadgeel, S., Soubani, A. O., Lonardo, F., Bepler, G., Schwartz, A. G., & Ethier, S. P. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31820a0ec0 · Cited by 82
Fukui, T., Tsuta, K., Furuta, K., Watanabe, S., Asamura, H., Ohe, Y., Maeshima, A. M., Shibata, T., Masuda, N., & Matsuno, Y. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00600.x · Cited by 82
Kozu, Y., Tsuta, K., Kohno, T., Sekine, I., Yoshida, A., WATANABE, S.-I. I., Tamura, T., Yokota, J., Suzuki, K., Asamura, H., et al. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.11.003 · Cited by 81
Tiseo, M., Rossi, G., Capelletti, M., Sartori, G., Spiritelli, E., Marchioni, A., Bozzetti, C., Palma, G. D., Lagrasta, C. A., Campanini, N., et al. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.04.021 · Cited by 80
Kuo, Y.-W., Wu, S., Ho, C., & Shih, J. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f43274 · Cited by 79
Miyazawa, H., Tanaka, T., Nagai, Y., Matsuoka, M., Huqun, Sutani, A., Udagawa, K., Zhang, J., Hirama, T., Murayama, Y., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00706.x · Cited by 79
Jiang, S., Yamashita, K., Yamamoto, M., Piao, C., Umezawa, A., Saegusa, M., Yoshida, T., Katagiri, M., Masuda, N., Hayakawa, K., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23868 · Cited by 78
Hirsch, F. R., Kabbinavar, F., Eisen, T., Martins, R., Schnell, F. M., Dziadziuszko, R., Richardson, K., Richardson, F., Wacker, B., Sternberg, D. W., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.4929 · Cited by 78
Restriction Endonuclease-Mediated Selective Polymerase Chain Reaction
Ward, R. L., Hawkins, N. J., O'grady, R., Sheehan, C. A., O'Connor, T. W., Impey, H., Roberts, N., Fuery, C. J., & Todd, A. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65581-2 · Cited by 77
Thu, K. L., Vucic, E. A., Chari, R., Zhang, W., Lockwood, W. W., English, J. C., Fu, R., Wang, P., Feng, Z., MacAulay, C. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033003 · Cited by 77
Tsao, M., Sakurada, A., Ding, K., Aviel‐Ronen, S., Ludkovski, O., Liu, G., Maître, A. L., Gandara, D. R., Johnson, D. H., Rigas, J. R., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181fd83a4 · Cited by 76
Lozano, M. D., Zulueta, J. J., Echeveste, J. I., Gúrpide, A., Seijo, L. M., Martín‐Algarra, S., del Barrio, A., Pı́o, R., Idoate, M. A., Labiano, T., et al. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0155 · Cited by 74
Genomic Profiles Specific to Patient Ethnicity in Lung Adenocarcinoma
Broët, P., Dalmasso, C., Tan, E. H., Alifano, M., Zhang, S., Wu, J., Lee, M. H., Régnard, J.-F., Lim, D., Koong, H. N., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2185 · Cited by 73
Fassina, A., Gazziero, A., Zardo, D., Corradin, M., Aldighieri, E., & Rossi, G. P. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.067587 · Cited by 73
Kawahara, A., Azuma, K., Sumi, A., Taira, T., Nakashima, K., Aikawa, E., Abe, H., Yamaguchi, T., Takamori, S., Akiba, J., et al. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.02.002 · Cited by 73
Moore, J. L., Aros, M. C., Steudel, K. G., & Cheng, K. C. (2002) · BioTechniques · doi:10.2144/02322st03 · Cited by 71
Jian, G., Zhou, S., Ling, Z., Qinfang, D., Jie, Z., Liang, T., & Caicun, Z. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0785-z · Cited by 70
Rizvi, N. A., Rusch, V. W., Pao, W. J., Chaft, J. E., Ladanyi, M., Miller, V. A., Krug, L. M., Azzoli, C. G., Bains, M. S., Downey, R. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2102 · Cited by 70
Self-citationLee, Y. J., Park, I. K., Park, M. S., Choi, H. J., Cho, B. C., Chung, K. S., Kim, S. K., Chang, J., Moon, J. W., Kim, H., et al. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0611-7 · Cited by 69
Hotta, K., Kiura, K., Toyooka, S., Takigawa, N., Soh, J., Fujiwara, Y., Tabata, M., Date, H., & Tanimoto, M. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318074bc0d · Cited by 68
Pintér, F., Pápay, J., Almási, A., Sápi, Z., Szabó, E., Kánya, M., Tamási, A., Jóri, B., Várkondi, E., Moldvay, J., et al. (2008) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.070125 · Cited by 67
Yang, J. C.-H., Schuler, M. H., Yamamoto, N., O'Byrne, K. J., Hirsh, V., Mok, T., Geater, S. L., Orlov, S. V., Tsai, C.-M., Boyer, M. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.18_suppl.lba7500 · Cited by 67
Sartori, G., Cavazza, A., Sgambato, A., Marchioni, A., Barbieri, F., Longo, L., Bavieri, M., Murer, B., Meschiari, E., Tamberi, S., et al. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcph0trmpxvzw2f · Cited by 66
Evaluation of EGFR mutation status in cytology specimens: An institutional experience
Aisner, D. L., Deshpande, C. G., Baloch, Z. W., Watt, C. D., Litzky, L. A., Malhotra, B., Sepulveda, A. R., Langer, C. J., Evans, T. L., & Deerlin, V. M. V. (2011) · Diagnostic Cytopathology · doi:10.1002/dc.21851 · Cited by 66
Haneda, H., Sasaki, H., Lindeman, N. I., Kawano, O., Endo, K., Suzuki, E., Shimizu, S., Yukiue, H., Kobayashi, Y., Yano, M., et al. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyi228 · Cited by 66
Self-citationEffects of fixation on polymerase chain reaction detection of Mycobacterium leprae
Fiallo, P., Williams, D. L., Chan, G. P., & Gillis, T. P. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.12.3095-3098.1992 · Cited by 65
Malapelle, U., Bellevicine, C., Zeppa, P., Palombini, L., & Troncone, G. (2010) · Diagnostic Cytopathology · doi:10.1002/dc.21512 · Cited by 65
Sone, T., Kasahara, K., Kimura, H., Nishio, K., Mizuguchi, M., Nakatsumi, Y., Shibata, K., Waseda, Y., Fujimura, M., & Nakao, S. (2007) · Cancer · doi:10.1002/cncr.22593 · Cited by 64
Sasaki, H., Endo, K., Okuda, K., Kawano, O., Kitahara, N., Tanaka, H., Matsumura, A., Iuchi, K., Takada, M., Kawahara, M., et al. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0320-z · Cited by 64
Test Verification and Validation for Molecular Diagnostic Assays
Halling, K. C., Schrijver, I., & Persons, D. L. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0212-ed · Cited by 64
Bosari, S., Marchetti, A., Buttitta, F., Graziani, D., Borsani, G., Loda, M., Bevilacqua, G., & Coggi, G. (1995) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199512000-00004 · Cited by 63
吉基, 神. (2011) · Medical Entomology and Zoology · Cited by 63
Cohen, V., Agulnik, J. S., Jarry, J., Batist, G., Small, D. I., Kreisman, H., Tejada, N. A., Miller, W. H., & Chong, G. (2006) · Cancer · doi:10.1002/cncr.22331 · Cited by 62
Heideman, D. A. M., Thunnissen, F. B., Doeleman, M., Kramer, D., Verheul, H. M., Smit, E. F., Postmus, P. E., Meijer, C. J. L. M., Meijer, G. A., & Snijders, P. J. F. (2009) · Analytical Cellular Pathology · doi:10.1155/2009/465850 · Cited by 62
Uramoto, H., Sugio, K., Oyama, T., Ono, K., Sugaya, M., Yoshimatsu, T., Hanagiri, T., Morita, M., & Yasumoto, K. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.08.006 · Cited by 61
Willmore‐Payne, C., Holden, J. A., & Layfield, L. J. (2006) · Human Pathology · doi:10.1016/j.humpath.2006.02.004 · Cited by 61
Bao Ming, Q. I. N., Chen, X., Zhu, J., & Duan Qing, P. E. I. (2005) · Cell Research · doi:10.1038/sj.cr.7290289 · Cited by 59
Li, J., Wang, L., Janne, P. A., & Makrigiorgos, G. M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.113381 · Cited by 57
ALK-Rearranged Lung Cancer: Adenosquamous Lung Cancer Masquerading as Pure Squamous Carcinoma
Chaft, J. E., Rekhtman, N., Ladanyi, M., & Riely, G. J. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31824c9485 · Cited by 56
Self-citationNaoki, K., Soejima, K., Okamoto, H., Hamamoto, J., Hida, N., Nakachi, I., Yasuda, H., Nakayama, S., Yoda, S., Satomi, R., et al. (2011) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0187-5 · Cited by 55
Mutations in BRCA1 from Fixed, Paraffin-Embedded Tissue Can Be Artifacts of Preservation
Wong, C., DiCioccio, R. A., Allen, H. J., Werness, B. A., & Piver, M. S. (1998) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(98)00079-x · Cited by 54
Park, S. H., Ha, S. Y., Lee, J.-I., Lee, H., Sim, H., Kim, Y. S., Hong, J., Park, J., Cho, E. K., Shin, D. B., et al. (2009) · Journal of Korean Medical Science · doi:10.3346/jkms.2009.24.3.448 · Cited by 54
Gandara, D. R., Grimminger, P., Mack, P. C., Lara, P. N., Li, T., Danenberg, P. V., & Danenberg, K. D. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181fd418d · Cited by 52
Ahn, M.-J., Park, B.-B., Ahn, J. S., Kim, S. W., Kim, H.-T., Lee, J. S., Kang, J. H., Cho, J. Y., Song, H. S., Park, S. H., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4608 · Cited by 52
ROS1 Rearrangements in Lung Cancer: A New Genomic Subset of Lung Adenocarcinoma
Janne, P. A., & Meyerson, M. M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.4197 · Cited by 50
Hasanovic, A., Ang, D. C., Moreira, A. L., & Zakowski, M. F. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.04.004 · Cited by 50
An Alternative Method for Screening EGFR Mutation Using RFLP in Non-small Cell Lung Cancer Patients
Kawada, I., Soejima, K., Watanabe, H., Nakachi, I., Yasuda, H., Naoki, K., Kawamura, M., Eguchi, K., Kobayashi, K., & Ishizaka, A. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318186fadd · Cited by 50
Oshita, F., Matsukuma, S., Yoshihara, M., Sakuma, Y., Ohgane, N., Kameda, Y., Saito, H., Yamada, K., Tsuchiya, E., & Miyagi, Y. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603396 · Cited by 50
Satouchi, M., Negoro, S., Funada, Y., Urata, Y., Shimada, T., Yoshimura, S., Kotani, Y., Sakuma, T., Watanabe, H., Adachi, S., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603710 · Cited by 48
High Efficacy of First-Line Gefitinib in Non-Asian Patients with EGFR-Mutated Lung Adenocarcinoma
Moiseyenko, V. M., Procenko, S. A., Levchenko, E., As, B., Moiseenko, F. V., Iyevleva, A. G., Mitiushkina, N. V., Togo, A. V., Semionov, I. I., Ivantsov, A. O., et al. (2010) · Onkologie · doi:10.1159/000302729 · Cited by 48
Analysis of ErbB Receptors in Pulmonary Carcinoid Tumors
Rickman, O. B., Vohra, P. K., Sanyal, B., Vrana, J. A., Aubry, M.-C., Wigle, D. A., & Thomas, C. F. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2549 · Cited by 47
Fan, X., Furnari, F. B., Cavenee, W. K., & Castresana, J. S. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.5.1023 · Cited by 46
Chen, C., Chang, J. W., Cheung, Y., Lin, G., Hsieh, J., Hsu, T., & Huang, S.-F. (2008) · Acta Radiologica · doi:10.1080/02841850802294410 · Cited by 45
The Effects of Tissue Fixation Alternatives on DNA Content: A Study on Normal Colon Tissue
Baloglu, G., Haholu, A., Küçükodacı, Z., Yılmaz, İ., Yıldırım, Ş., & Baloğlu, H. (2008) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e31815dffa6 · Cited by 45
Gefitinib in Advanced Non-Small Cell Lung Cancer: Does It Deserve a Second Chance?
Stinchcombe, T. E., & Socinski, M. A. (2008) · The Oncologist · doi:10.1634/theoncologist.2008-0019 · Cited by 45
Detection of EGFR Gene Mutations Using the Wash Fluid of CT-Guided Biopsy Needle in NSCLC Patients
Otani, H., Toyooka, S., Soh, J., Yamamoto, H., Suehisa, H., Kobayashi, N., Gobara, H., Mimura, H., Kiura, K., Sano, Y., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31816de2cd · Cited by 44
Ohtsuka, K., Ohnishi, H., Furuyashiki, G., Nogami, H., Koshiishi, Y., Ooide, A., Matsushima, S., Watanabe, T., & Goya, T. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)30407-x · Cited by 43
Xu, J., Han, Y., Duan, H. Q., Gao, E., Zhang, Y., Liu, X., Zhang, J. S., Toschi, L., Galetta, D., Azzariti, A., et al. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0512-1 · Cited by 43
Miyamae, Y., Shimizu, K., Mitani, Y., Araki, T., Kawai, Y., Baba, M., Kakegawa, S., Sugano, M., Kaira, K., Lezhava, A., et al. (2010) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2010.090105 · Cited by 43
Epidermal growth factor receptor kinase domain mutations are rare in salivary gland carcinomas
Dahse, R., Driemel, O., Schwarz, S., Dahse, J., Kromeyer-Hauschild, K., Berndt, A., & Kosmehl, H. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604875 · Cited by 41
Araki, J., Okamoto, I., Suto, R., Ichikawa, Y., & Sasaki, J.-I. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.10.012 · Cited by 41
Endo, K., Sasaki, H., Yano, M., Kobayashi, Y., Yukiue, H., Haneda, H., Suzuki, E., Kawano, O., & Fujii, Y. (2006) · Oncology Reports · doi:10.3892/or.16.3.533 · Cited by 38
Harada, T., Lopez-Chavez, A., Xi, L., Raffeld, M., Wang, Y., & Giaccone, G. (2011) · Oncogene · doi:10.1038/onc.2010.545 · Cited by 38
Self-citationDesign and Analytical Validation of Clinical DNA Sequencing Assays
Pont-Kingdon, G. A., Gedge, F., Wooderchak‐Donahue, W. L., Schrijver, I., Weck, K. E., Kant, J. A., Oglesbee, D., Bayrak‐Toydemir, P., Lyon, E., & _, _. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2010-0623-oa · Cited by 38
Morinaga, R., Okamoto, I., Fujita, Y., Arao, T., Sekijima, M., Nishio, K., Ito, H., Fukuoka, M., Kadota, J., & Nakagawa, K. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00962.x · Cited by 38
Kondo, M., Yokoyama, T., Fukui, T., Yoshioka, H., Yokoi, K., Nagasaka, T., Imaizumi, K., Kume, H., Hasegawa, Y., Shimokata, K., et al. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.06.008 · Cited by 38
Impact of HER2 and EGFR gene status on gefitinib‐treated patients with nonsmall‐cell lung cancer
Soh, J., Toyooka, S., Ichihara, S., Fujiwara, Y., Hotta, K., Suehisa, H., Kobayashi, N., Ichimura, K., Aoe, K., Aoe, M., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22818 · Cited by 33
Liu, Y., Xu, M., Zhong, H., Heng, W.-J., & Wu, B. (2008) · Pathology & Oncology Research · doi:10.1007/s12253-008-9113-1 · Cited by 33
Thunnissen, E., Bovée, J. V. M. G., Bruinsma, H., van den Brule, A. J. C., Dinjens, W. N. M., Heideman, D. A. M., Meulemans, E. V., Nederlof, P. M., van Noesel, C. J. M., Prinsen, C., et al. (2011) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200163 · Cited by 33
Self-citationBiological Prognostic and Predictive Factors in Lung Cancer
Rossi, A., Galetta, D., & Gridelli, C. (2009) · Oncology · doi:10.1159/000258500 · Cited by 31
Wu, J., Shih, J., Chen, K., Yang, C.-H., Yu, C., & Yang, P. (2011) · Medicine · doi:10.1097/md.0b013e31821a16f4 · Cited by 31
Garassino, M. C., Borgonovo, K., Rossi, A., Mancuso, A. P., Martelli, O., Tinazzi, A., Cosimo, S. D., Verde, N. M. L., Sburlati, P., Bianchi, C., et al. (2009) · PubMed · Cited by 31
Ohnishi, H., Ohtsuka, K., Ooide, A., Matsushima, S., Goya, T., & Watanabe, T. (2006) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200606000-00007 · Cited by 29
Erlotinib, gefitinib, or chemotherapy for EGFR mutation-positive lung cancer?
Mitsudomi, T. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70194-2 · Cited by 28
Lee, K. H., Kim, S., Suh, C., Han, Y. H., & Lee, J. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1280-6 · Cited by 26
EGFR/KRAS Mutations and Gefitinib Therapy in Chinese NSCLC Patients
Wang, Z., Wu, Y.-L. L. C., Zhang, G. C., Zhou, Q., Xu, C., & Guo, A. (2008) · Onkologie · doi:10.1159/000116736 · Cited by 25
Jennings, L. J., Smith, F. A., Halling, K. C., Persons, D. L., Kamel‐Reid, S., & _, _. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0136-oa · Cited by 24
Sueoka, N., Sato, A., Eguchi, H., Komiya, K., Sakuragi, T., Mitsuoka, M., Satoh, T., Hayashi, S., Nakachi, K., & Sueoka, E. (2006) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-006-0144-2 · Cited by 24
Kamel‐Reid, S., Zhang, T., Persons, D. L., Nikiforova, M. N., Halling, K. C., & _, _. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0220-oa · Cited by 23
Cohen, V., Agulnik, J. S., Ang, C., Kasymjanova, G., Batist, G., Small, D. I., Brandao, G., Chong, G., & Miller, W. H. (2010) · Cancer · doi:10.1002/cncr.25214 · Cited by 22
Pas, T. M. D., de Braud, F., Mandalà, M., Curigliano, G., Catania, C., Ferretti, G., Sozzi, P., Solli, P., & Goldhirsch, A. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00176-8 · Cited by 20
Croft, D. T., Jordan, R. M., Patney, H. L., Shriver, C. D., Vernalis, M., Orchard, T. J., & Ellsworth, D. L. (2008) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.070155 · Cited by 20
Saxe, D., Persons, D. L., Wolff, D. J., Theil, K. S., & _, _. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2010-0645-sa · Cited by 20
Argiris, A. E., Hensing, T. A., Yeldandi, A. V., Patel, S. Y., Raji, A. A., Sturgis, C. D., Masters, G. A., Gooding, W. E., Pins, M., & Kolesar, J. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31513-6 · Cited by 19
Hlinkova, K., Babál, P., Berzinec, P., Majer, I., & Ilenčíková, D. (2011) · Molecular Diagnosis & Therapy · doi:10.1007/bf03257190 · Cited by 15
Evaluation of 7q31 region improves the accuracy of EGFR FISH assay in non small cell lung cancer
Casorzo, L., Corigliano, M., Ferrero, P., Venesio, T., & Risio, M. (2009) · Diagnostic Pathology · doi:10.1186/1746-1596-4-36 · Cited by 15
Erlotinib in first-line therapy for non-small cell lung cancer: a prospective phase II study.
Choi, D. R., Lee, K. H., Choi, C., Kim, S., Suh, C., & Lee, J. (2011) · PubMed · Cited by 14
PCR-based testing for therapy-related EGFR mutations in patients with non-small cell lung cancer.
Dahse, R., Berndt, A., & Kosmehl, H. (2008) · PubMed · Cited by 14
A comparative study of EGFR mutation screening methods in non-small cell carcinoma of lung
Gombos, Z., Danihel, L., Puttaswamy, K., & Brose, M. S. (2010) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657301 · Cited by 7
Cited by
Zehir, A., Benayed, R., Shah, R. H., Syed, A., Middha, S., Kim, H. R., Srinivasan, P., Gao, J., Chakravarty, D., Devlin, S. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4333 · Cited by 3,380
Self-citationStandards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
Li, M. M., Datto, M., Duncavage, E. J., Kulkarni, S., Lindeman, N. I., Roy, S., Tsimberidou, A. M., Vnencak-Jones, C. L., Wolff, D. J., Younes, A., et al. (2017) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.10.002 · Cited by 2,030
Self-citationLindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., et al. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0388-cp · Cited by 936
Self-citationMolecular profiling for precision cancer therapies
Malone, E. R., Oliva, M., Sabatini, P. J. B., Stockley, T. L., & Siu, L. L. (2020) · Genome Medicine · doi:10.1186/s13073-019-0703-1 · Cited by 913
Wu, S.-G., & Shih, J.-Y. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0777-1 · Cited by 778
Metadata
- Authors
- Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., Thunnissen, E., & Ladanyi, M.
- Venue
- The Journal of Molecular Diagnostics
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 15
- Issue
- 4
- Pages
- 415-453
- ISSN
- 1525-1578 (ISSN-L)
- OpenAlex
- W2138200001
- Cited by
- 462
- References
- 318
- FWCI
- 54.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.